| Fiscal period | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Period End Date | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 |
|---|
| Sales | 879.52 | 539.01 | 713.51 | 675.57 | 591.25 | 521.07 | 468.54 | 499.26 | 563.58 | 654.12 |
| Total Revenues | 879.52 | 539.01 | 713.51 | 675.57 | 591.25 | 521.07 | 468.54 | 499.26 | 563.58 | 654.12 |
| Cost of sales | 322.61 | 208.28 | 267.58 | 248.01 | 214.97 | 194.60 | 179.07 | 212.22 | 234.80 | 246.93 |
| Gross Margin | 556.90 | 330.73 | 445.94 | 427.56 | 376.29 | 326.47 | 289.47 | 287.04 | 328.78 | 407.19 |
| Selling, general, and administrative expenses | 406.46 | 260.65 | 341.21 | 332.83 | 295.54 | 258.79 | 228.27 | 233.63 | 250.03 | 325.80 |
| Impairment of goodwill | -- | -- | -- | -- | (2.12) | (5.66) | -- | -- | -- | (1.81) |
| Gain on termination of license | -- | -- | -- | -- | -- | 4.65 | -- | -- | -- | 198.84 |
| Impairment gain / loss | (2.39) | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | -- | 128.77 |
| Income from operations | 148.05 | 70.08 | 104.73 | 94.73 | 78.62 | 66.68 | 61.20 | 53.40 | 78.75 | 278.41 |
| Interest expense | 2.83 | 1.97 | 2.15 | 2.58 | 1.99 | 2.34 | 2.83 | 1.48 | 1.38 | 1.65 |
| Litigation expense | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Realized gain on sale of investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest and dividend income | 3.40 | 2.87 | 3.69 | 3.96 | 2.98 | 3.33 | 3.00 | 3.89 | 4.44 | 1.13 |
| Gain (loss) on subsidiary’s issuance of stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Loss (gain) on foreign currency | 2.34 | (2.18) | (1.13) | (0.25) | (1.55) | (0.60) | (0.88) | 0.90 | (1.17) | (3.13) |
| Other income | 0.05 | 0.55 | -- | -- | -- | -- | -- | -- | -- | -- |
| Income before income taxes | 151.02 | 69.35 | 105.15 | 95.86 | 78.07 | 67.07 | 60.50 | 56.72 | 80.65 | 274.77 |
| Income taxes | 40.99 | 19.38 | 29.08 | 26.14 | 22.81 | 23.83 | 21.53 | 19.37 | 29.68 | 97.88 |
| Current-Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | 2.51 |
| Current-State and local | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.56 |
| Deferred-State and local | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.04 |
| Deferred-Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.70 |
| Current-Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | 102.72 |
| Deferred-Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | (8.65) |
| Minority interest in net income of consolidated subsidiary | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income before noncontrolling interest | 110.03 | 49.97 | 76.07 | 69.72 | 55.25 | 43.25 | 38.97 | 37.35 | 50.97 | 176.89 |
| Less net income attributable to the noncontrolling interest | 22.62 | 11.75 | 15.82 | 15.92 | 13.66 | 9.92 | 8.53 | 7.91 | 11.76 | 45.75 |
| Effect of Dilutive Securities of consolidated subsidiary adjustment | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) Numerator for Diluted Earnings Per Share | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income attributable to Inter Parfums, Inc | 87.41 | 38.22 | 60.25 | 53.79 | 41.59 | 33.33 | 30.44 | 29.44 | 39.21 | 131.14 |
| Basic net income attributable to Inter Parfums, Inc. common shareholders | 2.76 | 1.21 | 1.92 | 1.72 | 1.33 | 1.07 | 0.98 | 0.95 | 1.27 | 4.29 |
| Diluted net income attributable to Inter Parfums, Inc. common shareholders | 2.75 | 1.21 | 1.90 | 1.71 | 1.33 | 1.07 | 0.98 | 0.95 | 1.27 | 4.26 |
| Weighted average-basic number of shares outstanding | 31.68 | 31.54 | 31.45 | 31.31 | 31.17 | 31.07 | 31.00 | 30.93 | 30.76 | 30.58 |
| Weighted average-diluted number of shares outstanding | 31.84 | 31.66 | 31.69 | 31.52 | 31.31 | 31.18 | 31.10 | 31.06 | 30.95 | 30.72 |